Acknowledgement
Supported by : Tarbiat Modarres University, Tehran University of Medical Sciences
References
- Herishanu Y, Katz BZ, Lipsky A, Wiestner A. Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications. Hematol Oncol Clin North Am 2013;27:173-206. https://doi.org/10.1016/j.hoc.2013.01.002
- Bauer K, Rancea M, Roloff V, et al. Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia. Cochrane Database Syst Rev 2012;11:CD008079.
- Charbotel B, Fervers B, Droz JP. Occupational exposures in rare cancers: A critical review of the literature. Crit Rev Oncol Hematol 2014;90:99-134. https://doi.org/10.1016/j.critrevonc.2013.12.004
- Parker TL, Strout MP. Chronic lymphocytic leukemia: prognostic factors and impact on treatment. Discov Med 2011;11:115-23.
- Inamura K. Major tumor suppressor and oncogenic non-coding RNAs: clinical relevance in lung cancer. Cells 2017;6:E12. https://doi.org/10.3390/cells6020012
- Taheri M, Habibi M, Noroozi R, et al. HOTAIR genetic variants are associated with prostate cancer and benign prostate hyperplasia in an Iranian population. Gene 2017;613:20-4. https://doi.org/10.1016/j.gene.2017.02.031
- Tripathi V, Shen Z, Chakraborty A, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet 2013;9:e1003368. https://doi.org/10.1371/journal.pgen.1003368
- Ahmadi J, Kaviani Gebelli S, Atashi A. Evaluation of MALAT1 gene expression in AML and ALL cell lines. Faslnamahi Kumish 2015;17:179-86.
- Cho SF, Chang YC, Chang CS, et al. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. BMC Cancer 2014;14:809. https://doi.org/10.1186/1471-2407-14-809
- Janbabaei G, Hedayatizadeh-Omran A, Alizadeh-Navaei R, et al. An epidemiological study of patients with breast cancer in Northern Iran, between 2006 and 2015. WCRJ 2016;3:e803.
- Dykes IM, Emanueli C. Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genomics Proteomics Bioinformatics 2017;15:177-86. https://doi.org/10.1016/j.gpb.2016.12.005
- Li J, Xuan Z, Liu C. Long non-coding RNAs and complex human diseases. Int J Mol Sci 2013;14:18790-808. https://doi.org/10.3390/ijms140918790
- Eftekharian MM, Ghafouri-Fard S, Soudyab M, et al. Expression analysis of long non-coding RNAs in the blood of multiple sclerosis patients. J Mol Neurosci 2017;63:333-41. https://doi.org/10.1007/s12031-017-0982-1
- Rahimi H, Sadeghian MH, Keramati MR, et al. Cytogenetic abnormalities with interphase FISH method and clinical manifestation in chronic lymphocytic leukemia patients in North-East of Iran. Int J Hematol Oncol Stem Cell Res 2017;11:217-24.
- Balatti V, Pekarky Y, Rizzotto L, Croce CM. miR deregulation in CLL. Adv Exp Med Biol 2013;792:309-25.
- Sadighi S, Jahanzad I, Ali Mohagheghi M, et al. Somatic mutation in immunoglobulin gene variable region in patients with chronic lymphoid leukemia and its influence on disease prognosis. Middle East J Rehabil Health Stud 2016;2:e35848.
- Ronchetti D, Manzoni M, Agnelli L, et al. lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome. Blood Cancer J 2016;6:e468. https://doi.org/10.1038/bcj.2016.77
- Amodio N, Stamato MA, Juli G, et al. Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. Leukemia 2018;32:1948-57. https://doi.org/10.1038/s41375-018-0067-3
- Lamothe B, Cervantes-Gomez F, Sivina M, Wierda WG, Keating MJ, Gandhi V. Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemia. Blood 2015;125:407-10. https://doi.org/10.1182/blood-2014-07-585364
- Kuhn DJ, Chen Q, Voorhees PM, et al. Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitinproteasome pathway, against preclinical models of multiple myeloma. Blood 2007;110:3281-90.
- Zent CS. Time to test CLL p53 function. Blood 2010;115:4154-5. https://doi.org/10.1182/blood-2010-02-268482
- Kay NE, Suen R, Ranheim E, Peterson LC. Confirmation of Rb gene defects in B-CLL clones and evidence for variable predominance of the Rb defective cells within the CLL clone. Br J Haematol 1993;84:257-64. https://doi.org/10.1111/j.1365-2141.1993.tb03061.x
- Huang JL, Liu W, Tian LH, et al. Upregulation of long non-coding RNA MALAT-1 confers poor prognosis and influences cell proliferation and apoptosis in acute monocytic leukemia. Oncol Rep 2017;38:1353-62. https://doi.org/10.3892/or.2017.5802
- Isin M, Ozgur E, Cetin G, et al. Investigation of circulating lncRNAs in B-cell neoplasms. Clin Chim Acta 2014;431:255-9. https://doi.org/10.1016/j.cca.2014.02.010
- Wang X, Sehgal L, Jain N, Khashab T, Mathur R, Samaniego F. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2. J Transl Med 2016;14:346. https://doi.org/10.1186/s12967-016-1100-9
- Li LJ, Chai Y, Guo XJ, Chu SL, Zhang LS. The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma. Biomed Pharmacother 2017;89:939-48. https://doi.org/10.1016/j.biopha.2017.02.011
- Kim SH, Kim SH, Yang WI, Kim SJ, Yoon SO. Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphoma. Oncotarget 2017;8:31305-17.
- Kokhaee P. B-cell chronic lymphocyte leukemia (B-CLL). Faslnamahi Kumish 2007;9:1-12.
- Yoon JH, Kim Y, Yahng SA, et al. Validation of Western common recurrent chromosomal aberrations in Korean chronic lymphocytic leukaemia patients with very low incidence. Hematol Oncol 2014;32:169-77. https://doi.org/10.1002/hon.2103
Cited by
- Network Diffusion Approach to Predict LncRNA Disease Associations Using Multi-Type Biological Networks: LION vol.10, pp.None, 2018, https://doi.org/10.3389/fphys.2019.00888
- Long Non-Coding RNA in the Pathogenesis of Cancers vol.8, pp.9, 2019, https://doi.org/10.3390/cells8091015
- Genetics of blood malignancies among Iranian population: an overview vol.15, pp.1, 2018, https://doi.org/10.1186/s13000-020-00968-2
- Long Noncoding RNA MALAT1 and Regulation of the Antioxidant Defense System in Diabetic Retinopathy vol.70, pp.1, 2018, https://doi.org/10.2337/db20-0375
- Long non-coding RNA MALAT1 modulate cell migration, proliferation and apoptosis by sponging microRNA-146a to regulate CXCR4 expression in acute myeloid leukemia vol.26, pp.1, 2021, https://doi.org/10.1080/16078454.2020.1867781